Drug Discovery

It's time to rewrite the narrative about Africa's role in the pharmaceutical industry.

Oncology research has come a long way over the past 30 years, but we must transform outdated practices to further improve drug discovery innovation.

How is the changing landscape of microbiome R&D shaping conversations with regulators?

Male animal bias in preclinical research isn’t scientifically justified and may be skewing our understanding of the brain.

Innovation in the ENT space is lacking. Lyra Therapeutics is, therefore, trying to create solutions for patient with unmet clinical needs.

Sitting Down With… Joan Mannick, Co-Founder and Chief Medical Officer at resTORbio, Massachusetts, USA.

Can the innate immune system be reprogrammed to fight cancer? Inmune Bio believes the answer is yes.

Georg Winter has cinched Eppendorf's 2019 Young European Scientist award.

SPaeDD, a collaborative effort between industry, academia and contractors, is helping to accelerate pediatric drug development in the UK..

Will the antibiotic apocalypse kill us all?